Original article Jeong Su Park1*, Kyu-Hwa Hur2*, Woo Jin Shin1, Hyunji Kim1, Dong Woo Shin1, Kyoung Un Park1 1Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea2Department of Laboratory Medicine, Green Cross Laboratories, Yongin, Korea*These authors contributed equally to this work. Correspondence to Jeong Su Park, E-mail: mdmicrobe@gmail.com Ann Clin Microbiol 2025;28(4):24. https://doi.org/10.5145/ACM.2025.28.4.5Received on 12 November 2025, Revised on 10 December 2025, Accepted on 10 December 2025, Published on 20 December 2025.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article which is freely available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract Background: Mycobacterium avium complex (MAC) is a major cause of pulmonary nontuberculous mycobacterial disease; however, treatment outcomes remain suboptimal. Phenotypic drug susceptibility testing (DST) is conditionally recommended; however, conventional broth microdilution is labor-intensive. The Sensititre SLOMYCO® panel offers a standardized platform for DST

Case report Joonsang Yu, Sihwan Kim, Kyu-Hwa Hur, Heungsup Sung, Mi-Na Kim Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea Corresponding to Mi-Na Kim, E-mail: mnkim@amc.seoul.kr Ann Clin Microbiol 2022;25(3):97-102. https://doi.org/10.5145/ACM.2022.25.3.5Received on 25 January 2022, Revised on 1 May 2022, Accepted on 17 May 2022, Published on 20 September 2022.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Bordetella hinzii is a nonfermenting, gram-negative rod and a rare opportunistic pathogen that can cause respiratory infections, bacteremia, and cholangitis. Here, we report the first case of bacteremia caused by B. hinzii in Korea. A 59-year-old man was admitted for the biopsy of a mass lesion in the left lower

Original article Kuenyoul Park1, Kyu-Hwa Hur2, Heungsup Sung1, Sang-Ho Choi3, Mi-Na Kim1 1Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 2Department of Laboratory Medicine, Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu, 3Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Corresponding to Heungsup Sung, E-mail: sung@amc.seoul.kr Ann Clin Microbiol 2022;25(2):41-46. https://doi.org/10.5145/ACM.2022.25.2.2Received on 11 February 2022, Revised on 1 April 2022, Accepted on 22 April 2022, Published on 20 June 2022.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: The concurrent detection of human cytomegalovirus (CMV) with UL97 and UL54 mutations is crucial for prescribing adequate antiviral treatment when drug-resistant CMV infection is suspected.